Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / / editor Jan B. Vermorken.
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | London, England : : Future Medicine Ltd,, 2013. 2013 |
| Year of Publication: | 2013 |
| Language: | English |
| Series: | Future Medecine,
|
| Online Access: | |
| Physical Description: | 1 online resource (111 pages) :; illustrations. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
5005092475 |
|---|---|
| ctrlnum |
(MiAaPQ)5005092475 (Au-PeEL)EBL5092475 (CaPaEBR)ebr11451923 (OCoLC)851776810 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / editor Jan B. Vermorken. London, England : Future Medicine Ltd, 2013. 2013 1 online resource (111 pages) : illustrations. text rdacontent computer rdamedia online resource rdacarrier Future Medecine, 2047-332X Includes bibliographical references at the end of each chapters and index. Description based on online resource; title from PDF title page (ebrary, viewed Noverber 7, 2017). Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Monoclonal antibodies Therapeutic use. HER-2 gene. HER-2 protein. Electronic books. Vermorken, Jan B., editor. Print version: Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment. London, England : Future Medicine Ltd, c2013 107 pages Future Medecine 9781780843292 ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=5092475 Click to View |
| language |
English |
| format |
eBook |
| author2 |
Vermorken, Jan B., |
| author_facet |
Vermorken, Jan B., |
| author2_variant |
j b v jb jbv |
| author2_role |
TeilnehmendeR |
| title |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / |
| spellingShingle |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / Future Medecine, |
| title_full |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / editor Jan B. Vermorken. |
| title_fullStr |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / editor Jan B. Vermorken. |
| title_full_unstemmed |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / editor Jan B. Vermorken. |
| title_auth |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / |
| title_new |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / |
| title_sort |
monoclonal antibodies targeting egfr/her2 and clinical outcomes in cancer treatment / |
| series |
Future Medecine, |
| series2 |
Future Medecine, |
| publisher |
Future Medicine Ltd, |
| publishDate |
2013 |
| physical |
1 online resource (111 pages) : illustrations. |
| isbn |
9781780843285 9781780843278 9781780843292 |
| issn |
2047-332X |
| callnumber-first |
R - Medicine |
| callnumber-subject |
RC - Internal Medicine |
| callnumber-label |
RC271 |
| callnumber-sort |
RC 3271 M65 M666 42013 |
| genre |
Electronic books. |
| genre_facet |
Electronic books. |
| url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=5092475 |
| illustrated |
Illustrated |
| dewey-hundreds |
600 - Technology |
| dewey-tens |
610 - Medicine & health |
| dewey-ones |
615 - Pharmacology & therapeutics |
| dewey-full |
615.37 |
| dewey-sort |
3615.37 |
| dewey-raw |
615.37 |
| dewey-search |
615.37 |
| oclc_num |
851776810 |
| work_keys_str_mv |
AT vermorkenjanb monoclonalantibodiestargetingegfrher2andclinicaloutcomesincancertreatment |
| status_str |
n |
| ids_txt_mv |
(MiAaPQ)5005092475 (Au-PeEL)EBL5092475 (CaPaEBR)ebr11451923 (OCoLC)851776810 |
| is_hierarchy_title |
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1792330964110671873 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01929nam a2200445 i 4500</leader><controlfield tag="001">5005092475</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200923020339.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">171107t20132013enka ob 001 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781780843292</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780843285</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780843278</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5005092475</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL5092475</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr11451923</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)851776810</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC271.M65</subfield><subfield code="b">.M666 2013</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.37</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment /</subfield><subfield code="c">editor Jan B. Vermorken.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, England :</subfield><subfield code="b">Future Medicine Ltd,</subfield><subfield code="c">2013.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (111 pages) :</subfield><subfield code="b">illustrations.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Future Medecine,</subfield><subfield code="x">2047-332X</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references at the end of each chapters and index.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (ebrary, viewed Noverber 7, 2017).</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Monoclonal antibodies</subfield><subfield code="x">Therapeutic use.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">HER-2 gene.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">HER-2 protein.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vermorken, Jan B.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment.</subfield><subfield code="d">London, England : Future Medicine Ltd, c2013 </subfield><subfield code="h">107 pages </subfield><subfield code="k">Future Medecine </subfield><subfield code="z">9781780843292</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=5092475</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |